Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats by Suryanarayana, Palla et al.
Curcumin and Turmeric Delay Streptozotocin-Induced
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Kamala Krishnaswamy, and G. Bhanuprakash Reddy
PURPOSE. The purpose of this study was to investigate the effect
of curcumin and its source, turmeric, on streptozotocin-in-
duced diabetic cataract in rats.
METHODS. Wistar-NIN rats were selected and diabetes was in-
duced by streptozotocin (35 mg/kg body weight, intraperito-
neally) and divided into four groups (group II-V). The control
(group I) rats received only vehicle. Group I and II animals
received an unsupplemented AIN-93 diet, and those in groups
III, IV, and V received 0.002% and 0.01% curcumin and 0.5%
turmeric, respectively, in an AIN-93 diet for a period of 8
weeks. Cataract progression due to hyperglycemia was moni-
tored by slit lamp biomicroscope and classified into four stages.
At the end of 8 weeks, the animals were killed and the bio-
chemical pathways involved in the pathogenesis of cataract
such as oxidative stress, polyol pathway, alterations in protein
content and crystallin profile in the lens were investigated, to
understand the possible mechanism of action of curcumin and
turmeric. Blood glucose and insulin levels were also deter-
mined.
RESULTS. Although, both curcumin and turmeric did not pre-
vent streptozotocin-induced hyperglycemia, as assessed by
blood glucose and insulin levels, slit lamp microscope obser-
vations indicated that these supplements delayed the progres-
sion and maturation of cataract. The present studies suggest
that curcumin and turmeric treatment appear to have coun-
tered the hyperglycemia-induced oxidative stress, because
there was a reversal of changes with respect to lipid peroxi-
dation, reduced glutathione, protein carbonyl content and ac-
tivities of antioxidant enzymes in a significant manner. Also,
treatment with turmeric or curcumin appears to have mini-
mized osmotic stress, as assessed by polyol pathway enzymes.
Most important, aggregation and insolubilization of lens pro-
teins due to hyperglycemia was prevented by turmeric and
curcumin. Turmeric was more effective than its corresponding
levels of curcumin.
CONCLUSIONS. The results indicate that turmeric and curcumin
are effective against the development of diabetic cataract in
rats. Further, these results imply that ingredients in the study’s
dietary sources, such as turmeric, may be explored for anti-
cataractogenic agents that prevent or delay the development of
cataract. (Invest Ophthalmol Vis Sci. 2005;46:2092–2099)
DOI:10.1167/iovs.04-1304
Chronic hyperglycemia is a major determinant in the devel-opment of secondary complications of diabetes, including
diabetic cataract. Studies indicate that hyperglycemia and the
duration of diabetes increase the risk of development of cata-
ract.1–3 Cataracts, characterized by cloudiness or opacification
of the crystalline eye lens, are the leading cause of blindness all
over the world—more so in developing countries.4 Apart from
aging, other risk factors such as nutritional deficiencies or
inadequacies, trace metals, sunlight, smoking, and certain
drugs are known to increase the risk of cataract.1–4 In view of
the widespread prevalence of diabetes in developing countries
such as India,5–7 diabetic cataract may pose a major problem in
the management of blindness.
Although the etiology of cataract is not fully understood,
oxidative damage to the constituents of the eye lens is consid-
ered to be a major mechanism in the initiation and progression
of various types of cataracts, including diabetic cataract.8 Dia-
betes causes increased oxidative stress in various tissues, as
evidenced by increased levels of oxidized DNA, proteins, and
lipids, which are thought to play an important role in the
pathogenesis of various diabetic complications.9 Several stud-
ies have suggested that intake of antioxidant-rich foods may
slow the progression of cataract.10–13
Dietary intervention, particularly the use of traditional foods
and medicines derived from natural sources, is the mainstay in
the management of diabetes. In this context, there has been a
growing interest in recent times in identifying as many dietary/
spice sources as possible for their ability to control diabe-
tes.12,14,15 Nevertheless, most studies of natural sources have
focused only on their ability to maintain blood glucose levels,
and have not been investigated for their beneficial effects on
secondary complications of diabetes such as cataract, retinop-
athy, nephropathy, and neuropathy. Therefore, we have been
interested in investigating various dietary sources for their
potential to prevent the secondary complications of diabetes,
such as cataract.16–18
Rhizome of turmeric (Curcuma longa L) is a widely used
spice in Indian cuisine. Curcumin (1,7-bis (4-hydroxy-3-me-
thoxyphenyl)-1,6.heptadiene-3,5-dione), the active portion of
turmeric, has been shown to have significant antioxidant ac-
tivity, both in vitro and in vivo,19–21 in addition to its various
other health-benefiting properties, such as anti-inflammatory,
anticarcinogenic, antiviral, hypolipidemic, and anti-infectious
effects.20–23 Earlier, it was reported that lenses obtained from
curcumin-treated rats are resistant to 4-hydroxy-2-transnonenal-
induced cataract formation in organ culture.24 Although later it
was demonstrated that dietary curcumin at a very low level
(0.0025%) attenuates galactose-induced cataract in rats, dose
dependency was not studied.25 To understand the role of
curcumin in preventing or delaying diabetic cataract in greater
detail, earlier we studied the effect of curcumin in a galactose-
induced cataract model with two levels of curcumin, 0.002%
and 0.01%, in the diet.16 Although curcumin delayed the onset
of cataract at both the levels, maturation was delayed by
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0.002% curcumin, but not by 0.01%. The maturation was, in
fact, faster with 0.01% curcumin.16
Because galactose-induced cataract does not mimic typical
diabetic human cataract, we decided to investigate these dif-
ferential effects of curcumin in another model, streptozotocin
(STZ)-induced diabetes. Moreover, the protective effect of tur-
meric, the source of curcumin, against cataract has not been
investigated. Hence, in the present study, we also investigated
the effect of turmeric against diabetic cataract and compared it
with that of curcumin.
METHODS
Materials
Streptozotocin (STZ), curcumin, NADPH, NADH, 2-thiobarbituric acid
(TBA), 1,1,3,3-tetraethoxy propane (TEP), DL-glyceraldehyde, lithium
sulfate, -mercaptoethanol, glutathione, BSA, 2,4-dinitrophenylhy-
drazine (DNPH), and EDTA were obtained from Sigma-Aldrich (St.
Louis, MO). All other chemicals and solvents were of analytical grade
and were obtained from local companies.
Experimental Design and Dietary Regimen
Three-month-old male WNIN rats with an average body weight of
228  13 g (obtained from the National Center for Laboratory Animal
Sciences, National Institute of Nutrition, Hyderabad) were used in the
study. All the animals were fed AIN-93 diet ad libitum. The control
(group I; n 8) rats received 0.1 M citrate buffer [pH 4.5] as a vehicle,
whereas the experimental rats received a single intraperitoneal injec-
tion of STZ (35 mg/kg) in citrate buffer. After 72 hours, fasting blood
glucose levels were monitored. Animals having blood glucose levels
145 mg/dL were excluded from the experiment and rest were dis-
tributed into four groups (groups II–V). Animals in these groups re-
ceived either only the AIN-93 diet (group II; n  13) or received the
AIN-93 diet containing 0.002% (group III; n  9) or 0.01% (group IV;
n  9) curcumin or 0.5% turmeric (group V; n  8) for a period of 8
weeks. Turmeric contains 1% to 2% curcumin and hence 0.5% turmeric
corresponds to approximately 0.01% curcumin.
Animal Care
Animal care and protocols were in accordance with and approved by
the Institutional Animal Ethics Committee. Animals were housed in
individual cages in a temperature- and humidity-controlled room with
a 12-hour light–dark cycle. All the animals had free access to water.
Food intake (daily) and body weights (weekly) were monitored. We
adhered to the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research.
Slit Lamp Examination and Cataract Classification
Eyes were examined every week using a slit lamp biomicroscope
(Kowa Portable, Japan) on dilated pupils. Initiation and progression of
lenticular opacity was graded into five categories as follows: clear,
clear lenses and no vacuoles present; stage 1, vacuoles cover approx-
imately one half of the surface of the anterior pole, forming a subcap-
sular cataract; stage 2, some vacuoles have disappeared and the cortex
FIGURE 1. The effect of curcumin and turmeric on STZ-induced cata-
ract after 5 (A) and 8 (B) weeks. In the calculation of the incidence of
lenses in various stages, total lenses in a group were considered to be
100%. (C) The effect of curcumin and turmeric on the average stage of
STZ-induced cataract, as a function of time.
FIGURE 2. The effect of curcumin and turmeric on blood glucose
levels in STZ-treated rats. Data are an average of all the animals in a
given group.
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exhibits a hazy opacity; stage 3, a hazy cortex remained and dense
nuclear opacity is present; and stage 4, a mature cataract is observed as
a dense opacity in both cortex and nucleus.
Blood and Lens Collection and Processing
Blood was collected once a week from the retro-orbital plexus for
glucose and insulin estimation. At the end of 8 weeks, animals were
killed by CO2 asphyxiation, and lenses were dissected by the posterior
approach and stored at 70°C until further analysis. A 10% homoge-
nate was prepared from three to five pooled lenses in 50 mM phos-
phate buffer (pH 7.4). All the biochemical parameters were analyzed in
the soluble fraction of the lens homogenate (15,000g at 4°C) except for
lens malondialdehyde (MDA), which was determined in the total ho-
mogenate.
Biochemical Estimations
Serum glucose was measured by the glucose oxidase-peroxidase (GOD-
POD) method26 in a commercially available kit (Ozone Biomedicals
Pvt. Ltd., New Delhi, India) and serum insulin by an RIA kit (BRIT-DAE,
Mumbai, India). Lens MDA, as thiobarbituric acid-reacting substances
(TBARS)27; protein carbonyl content28; and reduced glutathione
(GSH)29; and the activities of aldose reductase (AR)30 and sorbitol
dehydrogenase (SDH)31 were determined according to methods de-
scribed previously. The specific activities of superoxide dismutase
(SOD),32 glutathione peroxidase (GPx),33 and glucose-6-phosphate de-
hydrogenase (G6PD)34 were assayed according to reported methods.
Total, soluble, and insoluble protein was assayed by the Lowry method,
with BSA as a standard.
SDS-PAGE and Size Exclusion Chromatography
of Lens Proteins
The subunit profile and cross-linking of soluble proteins were analyzed
on 10% polyacrylamide gels in the presence of SDS under reducing
conditions. Crystallin distribution in the soluble protein fraction was
performed by size-exclusion chromatography on a 600  7.5 mm
column (TSK-G4000 SW; Tosoh Co., Tokyo, Japan) in an HPLC system
(Class-VP; Shimadzu, Kyoto, Japan). The column was equilibrated with
0.1 M sodium phosphate buffer (pH 6.7) containing 0.1 M sodium
chloride at a flow rate of 1 mL/min. Soluble protein samples (20 L of
1 mg/mL solution) were loaded onto the column, and protein peaks
were detected at 280 nm.
Statistical Analysis
One-way ANOVA was used for testing statistical significance between
groups of data, and individual pair difference was tested by means of
Duncan’s multiple-range test. Heterogeneity of variance was tested by
the nonparametric Mann-Whitney test. P  0.05 was considered sig-
nificant.
RESULTS
Food Intake and Body Weights
There was an increase in the food intake in all the diabetic
groups (II–V) compared with the control group (group I; data
not shown). Despite the increased food intake, the body
weight of group II animals was decreased (194g), when com-
pared with the control subjects (385g). However, the decrease
in body weight due to hyperglycemia was not ameliorated
either by treatment with curcumin or turmeric (data not
shown).
FIGURE 3. The effect of curcumin and turmeric on serum insulin
levels in STZ-treated rats. Data are the average  SD of results in all the
animals in a given group. a, significantly different from group I.
FIGURE 4. The effect of curcumin and turmeric on lipid peroxidation
in the lens. Data are the mean  SD (n  4). a, significantly different
from group I; b, significantly different from group II.
FIGURE 5. The effect of curcumin and turmeric on protein carbonyl
content in the lens. Data are the mean  SD (n  4). a, significantly
different from group I; b, significantly different from group II.
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Onset and Progression of Cataract
The onset of cataract was observed after 4 weeks by slit lamp
examination. Whereas all the lenses in group I were clear and
normal, in group II, 30% of the lenses were in stage 1, 60% in
stage 2, and 10% in stage 3 of cataract formation, and none of
them was clear after 5 weeks (Fig. 1A). However, group III
animals had 45% of the lenses in stage 1, 25% in stage 2, and
30% in stage 3, whereas in groups IV and V, most of the lenses
were in stage 1 and only a few were in stages 2 and 3 (Fig. 1A).
These results clearly indicate that treatment with turmeric and
curcumin delayed progression of hyperglycemia-induced cata-
ract. At the end of 8 weeks, most of the lenses (65%) in group
II showed development of mature (stage 4) cataract (Fig. 1B).
Remarkably, the percentage of mature cataract lenses de-
creased to 43%, 33%, and 25%, respectively, in groups III, IV,
and V (Fig. 1B). The data thus suggest that curcumin and
turmeric delayed maturation of diabetic cataract due to slow
progression. Because lenses were in different stages of cataract
in a given group at the given time, we averaged the stages at a
given time in a given group, to track the onset and progression
of cataract in an empiric manner in all the groups (Fig. 1C). The
data suggest that, although onset of cataract due to STZ-in-
duced hyperglycemia was not affected, progression and matu-
ration were delayed significantly in a dose-dependent manner
with curcumin treatment. The effect was even more pro-
nounced with turmeric treatment.
The Molecular Basis for the Delay of Cataract
To investigate the possible mechanisms by which curcumin
and turmeric delay the STZ-induced diabetic cataract, various
biochemical parameters related to cataractogenesis such as
oxidative stress/antioxidant system, the polyol pathway, pro-
tein oxidation, protein content, and crystallin distribution were
studied. In addition, we have also estimated blood glucose and
insulin levels. As expected, blood glucose levels were elevated,
and insulin levels were lowered significantly in group II com-
pared with those in group I (Figs. 2, 3). Nonetheless, treatment
with curcumin or turmeric did not reverse the changes in
blood glucose and insulin levels (Figs. 2, 3), indicating that
curcumin and turmeric treatment had no effect on the state of
STZ-induced hyperglycemia.
Oxidative Stress and the Antioxidant System
The increased TBARS levels in group II compared with the
control group indicate increased lipid peroxidation in the lens
due to hyperglycemia (Fig. 4). Protein carbonyl content, a
measure of oxidative damage to proteins, was found to be
increased in group II compared with group I, suggesting en-
hanced protein oxidation under hyperglycemic conditions
(Fig. 5). Further, decreased levels of reduced glutathione (GSH)
in group II (Fig. 6) suggest and support that there is increased
oxidative stress in diabetic cataractous lenses. However, treat-
ment with curcumin and turmeric prevented the alterations,
not only in TBARS, but also in protein carbonyls, despite
elevated glucose levels (Figs. 4, 5). Although GSH levels were
not returned to normal by curcumin and turmeric feeding, they
improved significantly with turmeric treatment when com-
pared with levels in untreated diabetic animals (Fig. 6). To-
gether, these data clearly demonstrate that turmeric and cur-
cumin prevent hyperglycemia-mediated lenticular oxidative
stress and may thus be one of the mechanisms by which
turmeric and curcumin delay the progression and maturation
of diabetic cataract. Increased specific activity of GPx and the
marginal decrease in G6PD observed in group II compared
with group I, further substantiate the role of oxidative stress in
cataractogenesis due to hyperglycemia (Table 1), though no
change in SOD activity was observed. Turmeric and curcumin
treatment prevented the altered activities of antioxidant en-
zymes (Table 1). Nevertheless, the mechanism of effect of
curcumin and turmeric on the enzyme activities needs further
investigation.
Polyol Pathway
While the specific activity of AR, a key enzyme of the polyol
pathway was significantly higher in group II animals than in
group I, sorbitol dehydrogenase activity was not significantly
altered (Table 2). Treatment with curcumin and turmeric re-
sulted in normalization of AR activity (Table 2). Based on these
results, it appears that curcumin and turmeric are effective
against osmotic stress caused by hyperglycemia. Although cur-
cumin has been shown to inhibit AR in vitro, the IC50 for in
vitro inhibition was far above the level fed to the animals in the
present study (Suryanarayana P, Reddy GB, unpublished data,
2004). Because an oxidative milieu is known to activate AR,
normalized activities may be due to the improved antioxidant
FIGURE 6. The effect of curcumin and turmeric on GSH levels in the
lens. Data are mean  SD (n  4). a, significantly different from group
I; b, significantly different from group II.
TABLE 1. The Effect of Curcumin/Turmeric on Activities of SOD, GPx, and G6PD in Rat Lenses
Enzyme Group I Group II Group III Group IV Group V
SOD 39.6  3.54 40.8  5.74 39.7  5.62 38.4  8.53 40.3  9.08
GPx 17.0  0.83 23.4  1.62* 21.1  1.31† 19.9  2.21† 20.8  1.01†
G6PD 5.2  0.36 4.2  0.55* 4.2  0.40 4.5  0.18 5.0  0.52†
The data are the mean  SD (n  4). SOD activity is expressed as units/min per 100 mg protein, and
the activity of GPx and G6PD is expressed as micromoles of NADPH oxidized/h per 100 mg protein and
micromoles of NADP reduced/h per 100 mg protein, respectively.
* Significantly different from group I.
† Significantly different from group II.
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status of the cell after curcumin and turmeric feeding rather
than to a direct inhibition of AR by curcumin.
Protein Aggregation and Insolubilization
Whatever the underlying mechanism, alterations in protein
profile, and insolubilization of otherwise soluble protein, have
been considered to be the ultimate change that results in lens
opacification. Therefore, we analyzed the total, soluble, and
insoluble protein content in all the groups. There was a signif-
icant decrease in both total and soluble protein in group II
compared with the control group (Table 3). Feeding the rats
curcumin and turmeric improved the total and soluble protein
levels. The ability of curcumin/turmeric to prevent the loss of
soluble protein of lens in STZ-treated rats was remarkable.
However, the improvement in the total and soluble protein
content was significant in groups IV and V but not in group III,
indicating that curcumin only at 0.01% levels and its corre-
sponding levels of turmeric (0.5%) prevented the loss of total
protein content, which is in agreement with the delay of
maturation of cataract in those groups (Fig. 1).
To investigate possible alterations in crystallin profile due to
diabetes-induced cataract and the influence of turmeric and
curcumin, the soluble proteins were analyzed by size-exclusion
chromatography. The distribution profile evidenced by HPLC
showed a decrease in - and -crystallin abundance in addition
to the appearance of a high molecular weight (HMW) aggre-
gate peak in the void volume in group II compared with group
I (Fig. 7, Table 4). However, there was no significant difference
in the -crystallin peaks (Fig. 7, Table 4). The decrease in -
and -crystallins suggests that protein modification and degra-
dation in diabetic cataract lens may be involved in the forma-
tion of HMW aggregates due to either cross-linking or aggre-
gation or some other changes (Fig. 7, Table 4). The SDS-PAGE
pattern of soluble protein (Fig. 8) showing an increased pro-
portion of cross-linked and aggregated proteins in the diabetic
rats (group II) compared with control (group I) rats substanti-
ates the HPLC data. Some amount of cross-linked and/or aggre-
gated proteins were also observed in the control group (Fig. 8,
bottom arrow), most probably due to age-related changes, as
these animals were more than 5 months old at the end of the
experiment. Further, these modifications were enhanced mark-
edly in the untreated diabetic group. Curcumin- and turmeric-
fed diabetic rats showed a crystallin profile similar to that in the
control rats (Figs. 7, 8; Table 4).
DISCUSSION
At present, the only treatment for cataract is surgery. It has
been estimated that a delay in cataract onset by 10 years could
reduce the need for cataract surgery by as much as half.35 Any
strategy that prevents or slows the progression of cataract has
a significant health impact. In this study, a diet including
curcumin and turmeric delayed the progression of diabetic
cataract in rats. Although, multiple mechanisms may contrib-
ute to these effects, the antioxidant effect of curcumin and
turmeric appears to be the predominant mechanism of action.
Although, there have been major advances in the control of
hyperglycemia (diabetes) through dietary changes, hypoglyce-
mic agents, insulin, and islet transplantation, the long-term
complications of diabetes, such as cataract, remain serious
problems. Various mechanisms have been proposed to explain
the pathophysiology of diabetic complications. These mainly
include oxidative stress, increased polyol pathway or osmotic
stress, increased formation of advanced glycation end prod-
ucts, activation of protein kinase C, and increased hexosamine
pathway flux.36 Although there is cross talk between these
pathways, results in several studies suggest that oxidative stress
is a major determinant in diabetic complications.9,16,36 There-
fore, agents or compounds that exert multiple actions, such as
antioxidant, antidiabetic/hypoglycemic, AR inhibitory, and an-
tiglycation properties could be more effective than agents with
a single action.
Curcumin, the major yellow phenolic curcuminoid present
in turmeric, has been reported to have a wide range of biolog-
ical activities. Earlier, we found that curcumin delays galactose-
induced cataract in rats only at very low amounts (0.002%) in
the diet; higher levels (0.01%) are not effective but rather
have deleterious effects.16 Although the galactose-cataract
model has been widely used, it should be noted that the
mechanism of galactose-induced cataract is different from typ-
ical diabetic cataract.37,38 In contrast to sorbitol, galactitol is
not further metabolized by sorbitol dehydrogenase in galac-
tosemia and may represent osmotic changes of sugar cataract
than oxidative stress.38 It is possible that the mechanism of
action of curcumin may be different under various conditions.
Hence, we set out to investigate the role of curcumin in the
prevention or delay of STZ-induced diabetic cataract. In addi-
tion, we studied the effects of turmeric, the source of cur-
cumin, an area that had not been investigated earlier.
TABLE 2. The Effect of Curcumin/Turmeric on Activities of Polyol Pathway Enzymes, AR, and SDH in
Rat Lenses
Enzyme Group I Group II Group III Group IV Group V
AR 22.6  0.70 29.2  3.23* 26.8  0.86† 22.4  1.81† 23.1  0.64†
SDH 3.6  0.53 4.0  1.24 3.9  0.01 3.5  1.01 3.1  0.94
The data are the mean  SD (n  4).
* Significantly different from group I.
† Significantly different from group II. AR activity is expressed as micromoles NADPH oxidised/h per
100 mg protein and SDH activity as micromoles NADH oxidized/h per 100 mg protein.
TABLE 3. The Effect of Curcumin/Turmeric on Protein Content of Rat Lenses
Parameter Group I Group II Group III Group IV Group V
Total protein (mg/g lens) 495  37.3 385  27.8* 398  53.1 472  48.3† 468  17.5†
Soluble protein (mg/g lens) 359  33.8 180  40.5* 237  50.3 297  39.1† 305  20.4†
Soluble protein (%) 72.5 46.9 59.7 62.9 65.1
The data are the mean  SD (n  4).
* Significantly different from group I.
† Significantly different from group II.
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In contrast to the results of galactose model,16 in the
present study, curcumin delayed the progression and matura-
tion of cataract in a dose-dependent manner. In addition, these
results substantiate the fact that the mechanism of cataract
formation and/or the actions of curcumin under different con-
ditions are dissimilar. Oxidative stress may be a predominant
mechanism in STZ-induced hyperglycemia and hence cur-
cumin is more effective in the STZ model. The increased
TBARS and protein carbonyls along with the decreased GSH
and altered activities of antioxidant enzymes in the present
study suggest increased oxidative stress in diabetic conditions.
The accumulation of carbonyl groups in proteins is generally
attributed to oxidative damage and is thought to contribute to
general protein dysfunction.39 A decrease in GSH and increase
in lipid peroxidation was observed in various types of cataract,
including diabetic cataract. As curcumin proved to be a poten-
tial antioxidant,19–23 it is possible that the delay of STZ-induced
cataract by curcumin is predominantly due to its antioxidant
activity. Furthermore, curcumin- and turmeric-influenced
changes in polyol pathway enzymes, particularly AR, in STZ-
induced hyperglycemia, further suggest that a combination of
AR inhibition and antioxidant potential could be more effective
than either of them alone.
The decrease in total and soluble protein content in group
II lenses compared with those in group I lenses in this study
could be due partly to leakage of proteins and insolubilization.
Curcumin and turmeric treatment not only prevented the de-
crease in total proteins but also prevented cross-linking/aggre-
gation and distribution of soluble proteins. The crystallin pro-
file of soluble protein suggests that the quality of the existing
soluble protein was also different between groups II and I. The
decrease in - and -crystallin peaks in diabetic group (group
II) may be the result of protein degradation or modification due
to oxidative stress. Furthermore, a small but reproducible
HMW peak that appeared in the void volume in group II
suggests formation of HMW aggregates. The HMW aggregates
probably were formed on cross-linking of degraded or modi-
fied proteins. However, the possibility of other changes con-
tributing to insolubilization cannot be ruled out. Nevertheless,
all these protein modifications were prevented by curcumin
and turmeric.
One of the important observations of this study was that
both turmeric and curcumin delayed the progression and mat-
uration of cataract, despite elevated levels of glucose. These
results thus provide a clue, for the first time, that turmeric or
curcumin may act downstream to glucose-mediated changes.
Although a study reported the ability of curcumin to lower the
glucose levels in alloxan-induced diabetic rats,40 other studies
have reported an antiglycation ability of curcumin that pre-
vents cross-linking of skin collagen in STZ-induced diabetic rats
and an improvement in metabolic status in terms of lipid
peroxidation and urinary excretion of electrolytes, despite no
effect on hyperglycemic status or body weight.41,42 The results
of these studies41,42 support the findings of the present study.
Further, our histologic and immunohistochemistry data on the
pancreas suggest that feeding of curcumin or turmeric had no
effect on changes due to STZ treatment (Kumar PU, Sury-
anarayana P, Reddy GB, unpublished data, 2004). These find-
FIGURE 7. The distribution profile of crystallins in the soluble fraction
in lenses in groups I and II. Soluble protein was loaded on a gel
filtration column, and protein peaks were detected at 280 nm. Peaks
representing an HMW aggregate and the -, - and -crystallins, are
indicated at their respective positions. a.u., arbitrary units for absor-
bance at 280 nm.
TABLE 4. The Distribution of Crystallins in Soluble Protein Fraction
Peak Group I Group II Group III Group IV Group V
HMW Peak 100 286 160 122 129
-Crystallin 100 93 94 96 94
-Crystallin 100 79 85 88 90
-Crystallin 100 85 86 92 98
The relative percentage of HPLC peaks in untreated and treated diabetic groups was calculated,
considering area under the curve for the respective peak in Group I as 100%. Data are the average of three
HPLC runs for the area under the curve.
FIGURE 8. The effect of curcumin and turmeric on protein cross-
linking and the aggregation of the soluble fraction of the lens. Soluble
protein was loaded onto a polyacrylamide gel. Right: molecular weight
standards; arrows: cross-linked proteins.
IOVS, June 2005, Vol. 46, No. 6 Curcumin Delay of Diabetic Cataract 2097
ings thus have an important bearing on the management of
secondary complications of diabetes for two reasons:
1. Although the impact of glycemic control in the preven-
tion of diabetic complications has been established by
studies such as the UK Prospective Diabetes Study and
Diabetes Control and Complications Trial, perfect glyce-
mic control is not always possible.
2. The Memory of glucose toxicity and the persistent pro-
gression of hyperglycemia-induced complications during
subsequent period of normal glucose homeostasis43–45
suggest that exclusive management of glucose can no
longer be viewed as sufficient for the control of long-
term complications. Hence, agents that can prevent di-
abetic complications, irrespective of glycemic control,
would have advantages in the management of secondary
complications.
Another interesting finding in this study is that turmeric was
more effective in delaying STZ-induced cataract than the cor-
responding level of curcumin (0.01%) that tumeric contains.
The pronounced effect of turmeric may be due to other ingre-
dients besides curcumin. It is for the first time that we report
that turmeric, at the levels that are close to average daily
intake,46,47 can be effective in preventing diabetic cataract in
rats. The dried rhizome of C. longa is a rich source of phenolic
compounds, the curcuminoids. Three main chemically related
curcuminoids were isolated from turmeric: curcumin, deme-
thoxycurcumin, and bisdemethoxy curcumin. In addition to
curcuminoids, turmeric contains protein, fat, minerals, carbo-
hydrates, and essential oils.46,47
Finally, although there is certainly a need to identify other
natural sources for their preventive or therapeutic use in dia-
betic complications, in this study we demonstrated yet another
beneficial property of an otherwise well-studied natural dietary
agent. Turmeric and curcumin provide a viable food-based,
as well as pharmacologic, approach to the treatment of
complications in diabetes. Therefore, delaying of cataract by
treatment with turmeric or curcumin merits further atten-
tion.
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